Burkett Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
DLA
MSV
FFA
KFP
RT
AAA
TFA
CP
VCM
Burkett Financial Services's BMY Position: Q3 2026 in Review
Burkett Financial Services increased its Bristol-Myers Squibb (BMY) stake by 2.6% in Q3 2026, buying an estimated $63 and bringing the position to 40 shares worth $2.52K. The position accounts for ﹤0.01% of the portfolio, ranked #348.
Burkett Financial Services first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. The position peaked at $90.9K in Q1 2024. 129 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Burkett Financial Services held 40 shares of Bristol-Myers Squibb worth $2.52K as of Q3 2026.
- Burkett Financial Services bought 1 Bristol-Myers Squibb share in Q3 2026, an estimated $63.
- Bristol-Myers Squibb made up ﹤0.01% of Burkett Financial Services's portfolio in Q3 2026, its #348 holding.
- Burkett Financial Services first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- Burkett Financial Services's Bristol-Myers Squibb position peaked at $90.9K in Q1 2024.
- 129 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.